Drotrecogin alpha (activated) in septic shock after lung transplant.

o the Editor: ince the first series by Daniels et al, there have been lmost no reports on the use of recombinant activated rotein C (rAPC; drotrecogin alfa; Xigris) in severe epsis after lung transplantation. Septic shock in this etting is very difficult to manage because it is almost nresponsive to conventional “aggressive” therapy. We report a 57-year-old… CONTINUE READING